相关实验视频

Updated: Jul 20, 2026

Synthesis of an Intein-mediated Artificial Protein Hydrogel

Synthesis of an Intein-mediated Artificial Protein Hydrogel

Published on: January 27, 2014

通过使用蛋白质中的蛋白质技术,设计一种长效,非偏倚的放松激素激动剂

Irina U Agoulnik¹, Elena M Kaftanovskaya¹, Courtney Myhr¹

¹Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.

Biochemical pharmacology

|June 30, 2024

概括

研究人员使用蛋白质中的蛋白质技术开发了一种长效的放松生物,以向纤维化. 这种新的方法增强了放松素.

科学领域:

内分泌学和药理学在内分泌学和药理学
生物技术和蛋白质工程生物技术和蛋白质工程
纤维化研究纤维化研究

背景情况:

激素放松素对于通过RXFP1受体激活来进行组织重塑至关重要.
放松素的矩阵修饰特性表明它有可能用于治疗纤维性疾病.
再组合放松素的短半衰期限制了心力衰竭等疾病的临床疗效.

研究的目的:

使用蛋白质中的蛋白质 (PiP) 技术设计一种长效的放松生物.
为了评估新型放松素-PiP结构的药理动力学和药理动力学特性.
评估Relaxin-PiP在肝纤维化小鼠模型中的治疗潜力.

主要方法:

使用PiP技术将单链人类放松素插入IgG骨干中.
在体外测试测量了受体结合,激活 (cAMP,cGMP,pERK) 和信号转导.
使用碳四化物诱导的小鼠肝纤维化模型来评估R2-PiP的疗效.

主要成果:

在小鼠中,Relaxin-PiP构造物具有大约4-5天的半衰期.
放松素-PiPs在人类和小鼠的RXFP1受体上表现出完全的激素活性,没有信号偏差.
R2-PiP治疗减少了肝损伤,原积累和Collagen1a1基因表达,同时增加了肝细胞的增殖.

结论:

蛋白质中的蛋白质技术成功地创造了一种长效的放松生物药物 (放松素-PiP).
放松素-PiP作为一种强大的RXFP1激动剂,在纤维性疾病中具有治疗潜力.
这些发现支持对治疗人类纤维状况的松/RXFP1信号传导进行进一步的研究.

关键词:

纤维化纤维化纤维化蛋白质中的蛋白质这是一个RXFP1的形式.放松放松放松放松

更多相关视频

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D

Published on: May 19, 2018

OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy

OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy

Published on: February 5, 2020

相关概念视频

Recombinant DNA

Recombinant DNA

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...